Digostics Resources
Please find below a selection of Digostics and GTT@home materials and resources for download.
Digostics Resources
Please find below a selection of Digostics and GTT@home materials and resources for download. urning visitors into lead
Case Studies
A Real-World Assessment of Gestational Diabetes (GDM) Home Testing at University Hospital Southampton (UHS)
Case study showcasing the results from UHS' implementation of GTT@home for GDM screening.
A Real-World Assessment of Gestational Diabetes (GDM) Home Testing at University Hospital Southampton (UHS)
Case study showcasing the results from UHS' implementation of GTT@home for GDM screening.
New Commissioner Guide to Health Equity
Featuring Digostics and GTT@home as a case study exemplar, Health Innovation KSS has published the Commissioner Guide to Health Equity to support health and social care commissioners in addressing health inequalities of access.
New Commissioner Guide to Health Equity
Featuring Digostics and GTT@home as a case study exemplar, Health Innovation KSS has published the Commissioner Guide to Health Equity to support health and social care commissioners in addressing health inequalities of access.
Research on Home Oral Glucose Tolerance Testing
A Clinical Evaluation of GTT@home Versus the In-Clinic Oral Glucose Tolerance Test (OGTT)
A Swansea University GDM study comparing the performance of GTT@home with the in-clinic OGTT.
A Performance Evaluation of GTT@home In an Antenatal Clinical Setting
A Swansea University GDM study evaluating GTT@home in a controlled antenatal clinical environment.
A Clinical Evaluation of GTT@home Versus the In-Clinic Oral Glucose Tolerance Test (OGTT)
A Swansea University GDM study comparing the performance of GTT@home with the in-clinic OGTT.
A Performance Evaluation of GTT@home In an Antenatal Clinical Setting
A Swansea University GDM study evaluating GTT@home in a controlled antenatal clinical environment.
Delayed Testing and Sub-Optimal Sample Processing During OGTT Misses More Than 50% of GDM Due to False Negatives
A research poster demonstrating the effect of preanalytical factors on accuracy of the OGTT.
Delayed Testing and Sub-Optimal Sample Processing During OGTT Misses More Than 50% of GDM Due to False Negatives
A research poster demonstrating the effect of preanalytical factors on accuracy of the OGTT.
Usability of a Home Oral Glucose Tolerance Test Kit - An Alternative to Clinic Visits - BMFMS
As featured at the 2024 British Maternal and Fetal Medicine Society conference in Liverpool, this poster showcases the usability results from UHS' implementation of GTT@home for GDM.
%20(1).png?width=154&name=GTT@home%20for%20GDM%20Datasheet%20Thumbnail%20(1)%20(1).png "GTT@home for GDM Datasheet Thumbnail (1) (1)")
Usability of a Home Oral Glucose Tolerance Test Kit - An Alternative to Clinic Visits - BMFMS
As featured at the 2024 British Maternal and Fetal Medicine Society conference in Liverpool, this poster showcases the usability results from UHS' implementation of GTT@home for GDM.
Usability of a Home Oral Glucose Tolerance Test Kit - An Alternative to Clinic Visits - ATTD
As featured at the 2024 Advanced Technologies and Treatments for Diabetes conference in Florence, this poster spotlights the usability results derived by UHS implementation of GTT@home for GDM.
.png?width=260&height=200&name=Poster%20Thumbnail%20PSD%20(1).png "Poster Thumbnail PSD (1)")
Usability of a Home Oral Glucose Tolerance Test Kit - An Alternative to Clinic Visits - ATTD
As featured at the 2024 Advanced Technologies and Treatments for Diabetes conference in Florence, this poster spotlights the usability results derived by UHS implementation of GTT@home for GDM.
Company and Solution Datasheets
Overview of GTT@home Managed Service
Digostics is proud to offer GTT@home, a revolutionary new diagnostic managed service that streamlines the diabetes screening workflow by taking effective and accurate OGTT directly to the patient.
Overview of GTT@home Managed Service
Digostics is proud to offer GTT@home, a revolutionary new diagnostic managed service that streamlines the diabetes screening workflow by taking effective and accurate OGTT directly to the patient.
GTT@home for Gestational Diabetes
Introducing GTT@home from Digostics - a ground-breaking new solution that is reshaping the way GDM is detected during pregnancy.
GTT@home for Gestational Diabetes
Introducing GTT@home from Digostics - a ground-breaking new solution that is reshaping the way GDM is detected during pregnancy.
GTT@home for Cystic Fibrosis Diabetes
GTT@home from Digostics is transforming the way cystic fibrosis diabetes is detected, offering a convenient and accurate home-based OGTT that reduces infection risk and makes regular annual testing more accessible for patients and care teams.
GTT@home for Cystic Fibrosis Diabetes
GTT@home from Digostics is transforming the way cystic fibrosis–related diabetes is detected, offering a convenient and accurate home-based OGTT that reduces infection risk and makes regular annual testing more accessible for patients and care teams.
GTT@home for Type 1 Diabetes
With GTT@home, Digostics is helping healthcare teams detect early-stage type 1 diabetes with greater ease and flexibility, streamlining OGTT delivery while maintaining clinical accuracy and improving patient experience.
GTT@home for Type 1 Diabetes
With GTT@home, Digostics is helping healthcare teams detect early-stage type 1 diabetes with greater ease and flexibility, streamlining OGTT delivery while maintaining clinical accuracy and improving patient experience.
GTT@home for Prediabetes and Type 2 Diabetes
Digostics’ GTT@home is changing how type 2 diabetes and prediabetes are identified - enabling patients to complete a reliable oral glucose tolerance test at home, supporting earlier diagnosis and more efficient disease prevention pathways.
GTT@home for Prediabetes and Type 2 Diabetes
Digostics’ GTT@home is changing how type 2 diabetes and prediabetes are identified - enabling patients to complete a reliable oral glucose tolerance test at home, supporting earlier diagnosis and more efficient disease prevention pathways.
GTT@home for Diabetes Detection in Reproductive Health
With GTT@home, Digostics is transforming how glucose testing supports women’s reproductive health - from PCOS and endometriosis to IVF - ensuring early, convenient, and precise detection of metabolic risk.
GTT@home for Diabetes Detection in Reproductive Health
With GTT@home, Digostics is transforming how glucose testing supports women’s reproductive health - from PCOS and endometriosis to IVF - ensuring early, convenient, and precise detection of metabolic risk.
GTT@home for Postpartum Hyperglycaemia
GTT@home from Digostics is redefining how postpartum glucose testing is delivered, making follow-up screening after pregnancy simpler, more accessible, and easier for women to complete at home.
GTT@home for Postpartum Hyperglycaemia
GTT@home from Digostics is redefining how postpartum glucose testing is delivered, making follow-up screening after pregnancy simpler, more accessible, and easier for women to complete at home.
GTT@home for Clinical Trials
Digostics’ GTT@home offers an innovative approach to glucose tolerance testing in research, enabling accurate, standardised, and participant-friendly data collection from any location.
GTT@home for Clinical Trials
Digostics’ GTT@home offers an innovative approach to glucose tolerance testing in research, enabling accurate, standardised, and participant-friendly data collection from any location.
GTT@home for Distributors
Digostics’ GTT@home represents a breakthrough in diabetes diagnostics - a trusted, proven solution that is expanding global access to high-quality glucose testing through strong local partnerships.
GTT@home for Distributors
Digostics’ GTT@home represents a breakthrough in diabetes diagnostics - a trusted, proven solution that is expanding global access to high-quality glucose testing through strong local partnerships.
Digostics Overview
Introducing Digostics and our ground-breaking work in diabetes home testing.
Digostics Overview
Introducing Digostics and our ground-breaking work in diabetes home testing.